logo
Search…
home
TOP News
Latest
RecommendHK StockUS StockChina StockMacroBond
Commercial
GlobalInvestment&FinancingCompany&ProductsCharacterESG
Economy&politics
Hong KongChinaAmerica
Stocks
HK StockChina StockUS Stock
Markets
HK StockUS Stock
IPO
Hong KongAmericaChina
Research
US StockHK Stock
Opinion
Recommendation
home
TOP News
Latest
RecommendHK StockUS StockChina StockMacroBond
Commercial
GlobalInvestment&FinancingCompany&ProductsCharacterESG
Economy&politics
Hong KongChinaAmerica
Stocks
HK StockChina StockUS Stock
Markets
HK StockUS Stock
IPO
Hong KongAmericaChina
Research
US StockHK Stock
Opinion
Recommendation
Search...
search
home
TOP News
Latest
RecommendHK StockUS StockChina StockMacroBond
Commercial
GlobalInvestment&FinancingCompany&ProductsCharacterESG
Economy&politics
Hong KongChinaAmerica
Stocks
HK StockChina StockUS Stock
Markets
HK StockUS Stock
IPO
Hong KongAmericaChina
Research
US StockHK Stock
Opinion
Recommendation
Home > Latest

Lates News

date
07/11/2025
Evergy company stated that the projects of Panasonic, Meta, and Google have driven the stable growth of electricity demand.
Latest
3 m ago
Eli Lilly (LLY.N): As part of an agreement with the Trump administration, it will receive a three-year tariff exemption.
3 m ago
According to White House sources, Lilly and Novo Nordisk will repatriate overseas revenue from their existing products and allow Medicaid programs in all states of the United States to benefit from most-favored-nation pricing.
3 m ago
Senior officials in the Trump administration: Eli Lilly and Novo Nordisk will lower the price of GLP-1 medications used to treat diabetes and other indications to $245 per month.
4 m ago
Lilly (LLY.US) and Novo Nordisk (NVO.US) both announced a straight line increase and reached an agreement with the US government to lower the price of GLP-1 while also obtaining a three-year tariff exemption. Senior officials of the Trump administration stated that approximately 10% of federal Medicare patients will be eligible to expand the use of GLP-1.
5 m ago
Senior officials of the Trump administration: Commercial health insurance companies will also be able to obtain GLP-1 medications at lower prices.
See all latestmore
logo
Contact US
qr
+852 - 60190728
gmteight@futurecultural.com
Customer Support
About Us
Contact Us
Frequently Asked
Privacy Policy
Terms of Use
Commercial Services
Advertising
Business Development
Copyright
Terms of Service
©️2013 - 2025 GMT EIGHT Holdings. All Rights Reserved.